Build status - In Progress
Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis
Recruiting
18 years - 70 years
All
Phase
3
5 participants needed
1 Location
Brief description of study
To investigate the safety and efficacy of Tradipitant versus placebo in relieving nausea and other symptoms of gastroparesis.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Diabetic Gastroparesis
-
Age: 18 years - 70 years
-
Gender: All
Male or Female, Age 18-70, Diagnosed with gastroparesis
Updated on
04 Aug 2024.
Study ID: 834091
Find a site
,
Your Information has been sent successfully.
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up
Send a message
Enter your contact details to connect with study team
Primary Contact
Interested in the study
Select a study center that’s convenient for you, and get in touch with the study team.
Contact a study centerPlease choose between Voice or SMS based delivery of verification code
or